Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 76 of 6351
-
Targeted bladder cancer drug takes on chemo in Late-Stage trial
Disease control Recruiting nowThe main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or symptoms of the cancer returning, or progressing) between Bacillus Calmette-Guérin (BCG) treated participants receiving …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a new pill boost the power of an existing leukemia treatment?
Disease control Recruiting nowAcute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are highly heterogeneous myeloid malignancies where few effective targeted therapies are available. While venetoclax has significantly advanced the treatment landscape, therapeutic resistance remains a critical chal…
Phase 1/2 • Sponsor: Chaser Therapeutics, Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for pancreatic cancer: targeted drug combo enters final trial phase
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy of QLS31905 in combination with chemotherapy (nab-paclitaxel plus gemcitabine \[AG\]) versus placebo in combination with chemotherapy (AG) in the treatment of CLDN18.2-positive advanced pancreatic cancer in adult participants.
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Double shock may save more cardiac arrest victims
Disease control Recruiting nowSome of the patients affected by Out-of-hospital cardiac arrest (OHCA) with ventricular fibrillation (VF)/ventricular tachycardia (VT) do not respond to initial defibrillation. The survival decreases with number of defibrillations required to terminate VF/VT. In 2022, one prospec…
Phase 2/3 • Sponsor: Gabriel Riva • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for aggressive breast cancer: experimental drug ESG401 enters final testing phase
Disease control Recruiting nowThe aim of this study is to evaluate the efficacy and safety of ESG401 as first-line treatment in patients with unresectable recurrent or metastatic triple-negative breast cancer.
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill aims to cut heart attacks in people with 'Hidden' cholesterol risk
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can CBD calm the brain in fragile x syndrome?
Disease control Recruiting nowThis study focuses on the therapeutic relevance of the endocannabinoid (eCB) system for the treatment of Fragile-X syndrome (FXS), the primary hereditary cause of autism spectrum disorder (ASD). Most individuals with FXS have moderate to severe intellectual disability (ID), and c…
Phase 2 • Sponsor: Université de Sherbrooke • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Balloon in the womb: new hope for babies with rare birth defect?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
Phase 3 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
Can smartphone volunteers beat ambulances to save overdose victims?
Disease control Recruiting nowOpioids are responsible for the greatest drug-related global health burden. Prevention and treatment programs for people with opioid use disorder are widely implemented, but further actions are required to reduce the mortality and morbidity caused by opioid use and dependence. We…
Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can CAR-T cells beat HIV? tiny trial aims for functional cure
Disease control Recruiting nowAutologous CAR-T cell therapy in HIV-1/AIDS patients
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New laser blood test could spot pancreatic cancer early
Diagnosis Recruiting nowLASERBLOOD is based on a biophotonic technology that can be used to predict the development of Pancreatic Ductal Adenocarcinoma (PDAC) in particular categories of subjects at risk (e.g. persons with diabetes, obese people, patients with Intraductal Papillary Mucinous Neoplasm \[I…
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
Triple PET imaging could sharpen epilepsy surgery targeting
Diagnosis Recruiting nowThis study focuses on the application value of 18F-FDG, SV2A, and TSPO PET imaging in the preoperative localization of epileptogenic foci in epilepsy. 18F-FDG PET detects glucose metabolism in brain tissue and is characterized by reduced metabolism during the interictal period. I…
Sponsor: Weibing Miao, PhD • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Could a phone app nudge people to exercise and slow Parkinson's before symptoms appear?
Prevention Recruiting nowThe goal of this clinical trial is two-fold. First to investigate the feasibility of whether a remotely administered smartphone app can increase the volume and intensity of physical activity in daily life in individuals with a LRRK2 G2019S or GBA1 N370S genetic mutation over a lo…
Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Can safety planning and therapy stop teen suicide? major trial in mozambique aims to find out.
Prevention Recruiting nowThis implementation research project aims to test the effectiveness and implementation outcomes of suicide safety planning along and a transdiagnostic cognitive behavioral intervention for suicide prevention on decreasing suicidal behaviors in secondary school students in Mozambi…
Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
New pill aims to control hepatitis b and boost immune response
Disease control Recruiting nowThrough regular monitoring of viral load, liver function and immune cell activity, the long-term efficacy of Adefovir in controlling HBV is precisely evaluated. By employing a dual mechanism of "antiviral action plus immune activation", it offers a novel therapeutic option for ac…
Phase 3 • Sponsor: Zhigang Ren • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a natural compound slow Alzheimer's decline?
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, double-dummy, active- and placebo-controlled, parallel-group clinical trial. The dose confirmation stage is designed to evaluate the efficacy and safety of different doses of huperzine A controlled-release tablets in patients…
Phase 2/3 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Massive study reveals Semaglutide's Heart-Protective power in obesity
Disease control CompletedThis study aims to evaluate the association of once-weekly semaglutide with the risk of cardiovascular (CV) and other obesity-related clinical outcomes in three study populations (Heart failure (HF), clinical Atherosclerotic Cardiovascular Disease (ASCVD), primary prevention). T…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New RNA drug aims to stop debilitating swelling attacks in rare genetic condition
Disease control Recruiting nowThis study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.
Phase 3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a cancer drug stop nerve tumors before they cause harm?
Prevention Recruiting nowPlexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was based on the finding that selumetinib shrinks the majority of PN in children with N…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
A second punch against hepatitis b: interferon after RNA drugs may clear the virus
Cure Recruiting nowThe goal of this clinical trial is to compare sequential PEG-IFNα therapy strategies in chronic hepatitis B (CHB) patients previously treated with ASO/siRNA. The main questions it aims to answer are: 1. Does sequential PEG-IFNα therapy (vs. deferred/no treatment) improve HBsAg c…
Sponsor: Huashan Hospital • Aim: Cure
Last updated Jul 31, 2026 00:00 UTC